Eric Ende
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Ende
Eric Ende is recorded as Chairman at Matinas BioPharma Holdings, Inc. (MTNB). Matinas BioPharma Holdings, Inc. reported in an 8-K filed March 14, 2025 that Eric Ende resigned as member of the Board, effective March 14, 2025. Matinas BioPharma Holdings, Inc. reported in an 8-K filed March 14, 2025 that Eric Ende resigned as Chairman of the Board, effective March 14, 2025.
“On March 13, 2025, Eric Ende informed the Board of Directors (the "Board") of Matinas BioPharma Holdings, Inc. (the "Company") that he was resigning as a member of the Board and as Chairman of the Board effective March 14, 2025, due to his other professional obligations.”
“On March 13, 2025, Eric Ende informed the Board of Directors (the "Board") of Matinas BioPharma Holdings, Inc. (the "Company") that he was resigning as a member of the Board and as Chairman of the Board effective March 14, 2025, due to his other professional obligations.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
2017-01-01–2025-03-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Matinas BioPharma Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Jerome D. Jabbour CEO, CFO, Board Member
- Hui Liu CTO
- Hui Liu, Ph.D., M.B.A. CTO
- Dr. Robin L. Smith Board Member
- Edward Neugeboren Board Member
- Evelyn D'An Board Member
- Evelyn D’An Board Member
- Jerome Jabbour Board Member
- Keith Murphy Board Member
- Robin L. Smith Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.